Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Grifols International | Contract Pharma

What are you searching for?

Sign in

Search by

Grifols International

Grifols International

Company Headquarters

152 Avinguda de la Generalitat , Sant Cugat del Vallès, CT, 08174, ES

Driving Directions Phone: View Phone
View website

Company Description

Grifols Partnership is a CDMO focused on added value injectable products, with a large international experience in the development and manufacturing of sterile drug products (small molecules) in glass vials and PP bags. Strict compliance with global manufacturing standards has earned us the highest accreditations, including authorizations by the U.S. FDA, EU and U.S. GMP and authorization for parametric release sterility.

Request more information from Grifols International

Request more information from Grifols International

Categories from Grifols International

Contract Development and Manufacturing Organization (CDMO)
Contract Manufacturing
Custom Manufacturing
Filling, Vial
Formulation Development
Manufacturing, Dose Form, Sterile
Manufacturing, Generics
Manufacturing, Injectables
Manufacturing, Parenterals, Large Volume
Manufacturing, Parenterals, Small Volume
Manufacturing, Veterinary
Parenterals Development
Parenterals, Vial Filling
Preformulation
Process Development/Scale-Up Services
Process R&D
Process Validation Studies
Project Management
QA/QC
R&D Services
Scale-Up
Serialization
Stability Studies
Stability, ICH
Sterile Filling
Sterility Testing
Technology Transfer

Related Content

Breaking News

Sanner Rebrands Gilero, Expands Chicago Facility

North American expansion strengthens CDMO support for medtech and healthcare packaging.

By: Charlie Sternberg

Breaking News

Lilly Breaks Ground on $6.5B Houston Manufacturing Site

The new Texas facility will produce Lilly’s oral GLP-1 medicine Foundayo and other small-molecule therapies.

By: Charlie Sternberg

Breaking News

WuXi XDC Secures GMP Release for Singapore Manufacturing Site

The designation applies to the site’s BCM3 antibody intermediate and conjugated drug substance dual-function production line, and DP4 facility.

By: Patrick Lavery

Breaking News

Made Scientific Acquires Cell Therapy Facility From National Resilience

The 85,000-sq.-ft. East Norriton site adds GMP cleanrooms, fill-finish capacity, and immediate onboarding for cell therapy sponsors.

By: Charlie Sternberg

News Releases

Upperton granted MHRA license for Annex 1 aligned sterile manufacturing facility.

Released By Upperton

Videos

The Friday Brief for September 18, 2026: Companies Expand in US & Europe

Hovione, Upperton, Piramal Pharma, Syntegon, Evonik, and Fareva opened or announced plans to build new facilities.

By: Patrick Lavery

Breaking News

CND Life Sciences Opens Innovation Lab in Scottsdale

New Scottsdale facility will support assay development, biomarker research and product innovation.

By: Charlie Sternberg

Breaking News

Upperton Gains MHRA Approval for Nottingham Sterile Manufacturing Site

License variation supports early-phase GMP manufacture at Nottingham facility.

By: Charlie Sternberg

Marco Gil, co-CEO, Hovione; Janice Mironov, Mayor, East Windsor, NJ; Debbie Hart, President, BioNJ; Antonio Almeida, co-CEO, Hovione; David Basile, VP of TechOps - Americas, Hovione

Breaking News

Hovione Doubles US Spray-Drying Capacity With Opening of New NJ Facility

This closes a $100 million investment cycle, and creates approximately 80 new jobs.

By: Patrick Lavery

Online Exclusives

CDMO Capacity: Stainless by Volume, Single-Use by Number

Large stainless-steel projects are rising, but pipeline demand is increasingly moving toward smaller, more flexible manufacturing models.

By: Dan Stanton

Sponsored Videos

Cohance Lifesciences: A Global CDMO Platform with Multi-Modality Expertise

Small Molecules. ADCs. Nucleic Acid Chemistry.

Released By Cohance Lifesciences

Breaking News

Fareva Expands CDMO Network With Türkiye Site

The Lüleburgaz facility adds major production capacity, technical expertise, and international client reach.

By: Charlie Sternberg

Videos

The Friday Brief for September 11, 2026: Facility Openings and Expansions

Meanwhile, bioprocessing and drug discovery drove some of the major new partnerships of the week.

By: Patrick Lavery

Breaking News

Lonza to Add Commercial Spray-Drying Facility in Oregon

The facility is expected to be completed in 2029, and will add 80 new jobs.

By: Patrick Lavery

Breaking News

VVMF Sydney Facility Gets Therapeutic Goods Manufacturing License

The company hopes this will expand access to advanced therapeutics manufacturing not only in Australia, but also across Asia-Pacific.

By: Patrick Lavery